Extracellular human immunodeficiency virus type 1 Tat protein promotes aggregation and adhesion of cerebellar neurons

Journal of Neuroscience

Volumn 16, Issue 8, 1996, Pages 2546-2552

  Orsini, Michael J ^a   Debouck, Christine M ^a,b   Webb, Christine L ^a   Lysko, Paul G ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Department of Molecular Genetics ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSACTIVATOR PROTEIN;

ADOLESCENT; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL AGGREGATION; CELL CULTURE; CEREBELLUM; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN IMMUNODEFICIENCY VIRUS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029886367     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-08-02546.1996     Document Type: Article

References (59)

1. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B (1995) Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 92:4838-4842.
2. Aldovini A, Debouck C, Feinberg MB, Rosenberg M, Arya SK, Wong-Staal F (1986) Synthesis of the complete trans-activation gene product of human T-lymphotrophic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro. Proc Natl Acad Sci USA 83:6672-6676.
3. Atwood WJ, Berger JR, Kaderman R, Tornatore CS, Major EO (1993) Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev 6:339-366.
4. Atwood WJ, Tornatore CS, Traub R, Conant K, Drew PD, Major EO (1994) Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells. AIDS Res Hum Retroviruses 10:1207-1211.
5. Barillari G, Buonaguro L, Fiorelli V, Hoffman J, Michaels F, Gallo RC, Ensoli B (1992) Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. J Immunol 149: 3727-3734.
6. Barillari G, Gendelman R, Gallo RC, Ensoli B (1993) The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 90:7941-7945.
7. Bayer P, Kraft M, Ejchart A, Westendorp M, Frank R, Rösch P (1995) Structural studies of HIV-1 Tat protein. J Mol Biol 247:529-535.
8. Brake DA, Debouck C, Biesecker G (1990a) Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivating protein, tat. J Cell Biol 111:1275-1281.
9. Brake DA, Goudsmit J, Krone W, Schammel P, Appelby N, Meloen RH, Debouck C (1990b) Characterization of murine monoclonal antibodies to the Tat protein from human immunodeficiency virus type 1. J Virol 64:962-965.
10. Buonaguro L, Buonaguro FM, Giraldo G, Ensoli B (1994a) The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J Virol 68:2677-2682.
11. Buonaguro L, Buonaguro FM, Tornesello ML, Beth GE, Del GE, Ensoli B, Giraldo G (1994b) Role of HIV-1 Tat in the pathogenesis of AIDS-associated Kaposi's sarcoma. Antibiot Chemother 46:62-72.
12. Denis M (1994) Tat protein from HIV-1 binds to Mycobacterium avium via a bacterial integrin. J Immunol 153:2072-2081.
13. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F (1990) Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84-86.
14. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC (1993) Release, uptake and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67:277-287.
15. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang H-K, Brady J, Gallo RC (1994) Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371:674-680.
16. Ensoli F, Cafaro A, Fiorelli V, Vannelli B, Ensoli B, Thiele CJ (1995) HIV-1 infection of primary human neuroblasts. Virology 210:221-225.
17. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B (1995) Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 95:1723-1734.
18. Frankel AD, Pabo CO (1988) Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55:1189-1193.
19. Gabuzda DH, Ho DD, De La Monte SM, Hirsch MS, Rota TR, Sobel RA (1986) Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 20:289-295.
20. Gait MJ, Karn J (1993) RNA recognition by the human immunodeficiency virus Tat and Rev proteins. Trends Biochem Sci 18:255-259.
21. Gallo P, Frei K, Rordorf C, Lazdins J, Tavolata B, Fontana A (1989) Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol 23:100-116.
22. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, Epstein LG, Gendelman HE (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV) infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176:1703-1718.
23. Giulian D, Vaca K, Noonan CA (1990) Secretion of neurotoxins by mononuclear phagocytes infected by HIV-1. Science 250:1593-1597.
24. Giulian D, Wendt E, Vaca K, Noonan CA (1993) The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci USA 90:2769-2773.
25. Gorman CM, Moffat LF, Howard BH (1982) Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2:1044-1051.
26. Hatta T, Tanaka O, Otani H (1994) Contribution of RGD sequence to neuronal migration in developing cerebral cortex. NeuroReport 5:2261-2264.
27. Hayman M, Arbuthnott G, Harkiss G, Brace H, Filippi P, Philippon V, Thomson D, Vigne R, Wright A (1993) Neurotoxicity of peptide analogues of the transactivating protein Tat from maedi-visna virus and human immunodeficiency virus. Neuroscience 53:1-6.
28. Jones KA, Peterlin BM (1994) Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 63:717-743.
29. Koenig S, Gendelman HE, Orenstein JM, DalCanto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093.
30. Kolson D, Buchhalter J, Collman R, Hellmig B, Farrell C, Debouck C, Gonzalez-Scarano F (1993) HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS Res Hum Retroviruses 9:677-685.
31. Kolson DL, Collman R, Hrin R, Balliet JW, Laughlin M, McGann KA, Debouck C, Gonzalez-Scarano F (1994) Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and transactivation. J Gen Virol 75:1927-1934.
32. Kuppuswamy M, Subramanian T, Srinivasan A, Chinnadurai G (1989) Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res 17:3551-3561.
33. Kure K, Llena JF, Lyman WD (1991) Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric and fetal brains. Hum Pathol 22:700-710.
34. Lysko PG, Nambi P (1993) Endothelin receptors in neural systems. Methods Neurosci 11:186-198.
35. Mabrouk K, Van Reitschoten J, Vives E, Darbon H, Rochat H, Sabatier JM (1991) Lethal neurotoxicity in mice of the basic domains of the HIV and SIV Rev proteins. Study of these regions by circular dichroism. FEBS Lett 289:13-17.
36. Madore SJ, Cullen BR (1993) Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J Virol 67:3703-3711.
37. Magnuson DSK, Knudson BE, Geiger JD, Brownstone RM, Nath A (1995) Human immunodeficiency virus type 1 Tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 37:373-380.
38. Marcuzzi A, Lowy I, Weinberger OK (1992) Transcellular activation of the human immunodeficiency virus type I long terminal repeat in T lymphocytes requires CD4-gp120 binding. J Virol 66:4536-4539.
39. Merrill JE, Chen ISY (1991) HIV-1, macrophages, glial cells and cytokines in AIDS nervous system disease. FASEB J 5:2391-2397.
40. Meyers G, Josephs SF, Berzofsky JA, Rabson AB, Smith TF, Wong-Staal F (1990) Human retroviruses and AIDS. Los Alamos, NM: Los Alamos National Laboratory.
41. Philippon V, Vellutini C, Gambarelli D, Harkiss G, Arbuthnott G, Metzger D, Roubin R, Filippi P (1994) The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology 205:519-529.
42. Pierschbacher M, Ruoslahti E (1986) Arg-Gly-Asp: a versatile cell recognition signal. Cell 44:517-518.
43. Roy S, Delling U, Chen CH, Rosen CA, Sonenberg N (1990) A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes Dev 4:1365-1373.
44. Sabatier J-M, Vives E, Mabrouk K, Benjouad A, Rouchat H, Duval A, Hue B, Bahraoui E (1991) Evidence for neurotoxic activity of Tat from human immunodeficiency virus type 1. J Virol 65:961-967.
45. Swingler S, Easton A, Morris A (1992) Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells. Aids Res Hum Retroviruses 8:487-493.
46. Tardieu M, Hery C, Peudeiner S, Boespflug O, Montaigner L (1992) Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell contact. Ann Neurol 32:11-17.
47. Taylor JP, Cupp C, Diaz A, Chowdhury M, Khalili K, Jimenez SA, Amini S (1992a) Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc Natl Acad Sci USA 89:9617-9621.
48. Taylor JP, Pomerantz R, Bagasra O, Chowdhury M, Rappaport J, Khalili K, Amini S (1992b) TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation. EMBO J 11:3395-3403.
49. Taylor JP, Kundu M, Khalili K (1993) TAR-independent activation of HIV-1 requires the activation domain but not the RNA binding domain of Tat. Virology 195:780-785.
50. Taylor JP, Pomerantz RJ, Oakes JW, Khalili K, Amini S (1995) A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 Tat. Oncogene 10:395-400.
51. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-193.
52. Tornatore C, Nath A, Amemiya K, Major EO (1991) Persistent human immunodeficiency type 1 infection in human fetal glial cells reactivated by T-cell factors or the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 65:6094-6100.
53. Truckenmiller ME, Kulaga H, Coggiano M, Wyatt R, Snyder SH, Sweetnam PM (1993) Human cortical neuronal cell line: a model for HIV-1 infection in an immature neuronal system. Aids Res Hum Retroviruses 9:445-453.
54. Tyor WR, Glass JD, Griffin JW, Becker PS (1992) Cytokine expression in the brain during the acquired immune deficiency syndrome. Ann Neurol 31:349-360.
55. Valerie K, Delers A, Bruck C, Thiriart C, Rosenberg H, Debouck C. Rosenberg M (1988) Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature 333:78-81.
56. Vogel J, Hinrichs SH, Reynolds RK, Luciw PA, Jay G (1988) The HIV Tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335:606-611.
57. Vogel B, Lee S-J, Hildebrand A, Craig W, Pierschbacher MD, Wong-Staal F, Ruoslahti E (1993) A novel integrin specificity exemplified by binding of the αvβ5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol 121:461-468.
58. Weeks BS, Desai K, Loewenstein PM, Klotman ME, Klotman PE, Green M, Kleinman HK (1993) Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90 kDa cell surface binding protein. J Biol Chem 268:5279-5284.
59. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83:7089-7093.